The Effect of Iron Supplementation on the Factors Affecting the Aerobic Capacity of Women Athletes

The Effect of Iron Supplementation on the Factors Affecting the Aerobic Capacity of Women Athletes

Clinical trial with control group and supplement group, double-blind, randomized, phase 3 on 14 patients, Excel software was used to evaluate the data.

Aerobic capacities of the participants will be measured using the Bruce test and the use of a gas analyzer (Gas Analyzer: Cortex Biophysic Germany), which will be manually entered into the treadmill data. In this way, after installing the device's heart rate sensor on the subject's chest and identifying it by the device, the subject's information including age and weight is entered and finally the Bruce test begins and the person performs the test with increasing intensity until the time of exhaustion. The end of maximum oxygen consumption of people is calculated and recorded by the device. The intervention with iron or placebo begins after measuring the research variables and continues for 3 weeks, and after the end of the three-week period, the subjects are re-tested. Both researchers and participants were blinded.

Completing the informed consent form and having full consent, not having any types of special and chronic diseases, the type and time of drug use (if used), not having pain in a specific area of the body

Supplemental group: daily recipient of 100 mg of iron (a 100 mg tablet of polymaltose iron trihydroxide complex) for 3 weeks Control group: receiving 100 mg of placebo daily (two mouth deodorizing tablets that are the same color and shape as iron tablets and are completely ineffective) for 3 weeks

Maximum aerobic power, pressure perception scale, time to reach stasis, pulmonary ventilation and respiratory efficiency including EQO2 and EQCO2

Simple randomization method with individual randomization unit: In this way, the 14 subjects of the present study were divided into two groups of 7 by the laboratory manager without considering any specific case among them.

In the present study, the subjects had no information about which of the two iron supplement and placebo groups they had taken, and they were kept blind in the study. The administration of the supplement and placebo was done by the laboratory official taking into account ethical considerations, so that they knew which package contained iron and which one contained placebo, and gave iron supplement to one group and placebo to another group. Is. After this step was done, only the researcher and supervisor were informed. The doctor in charge of the present study has also approved the permission to use iron supplements and has been involved in all stages of the work.

Because of students' unauthorized use of data and data creation through other people's data, which ultimately devalues other people's research.

Only part of the data, such as the main outcome information, will be available only to researchers working in academic and scientific institutions after de-identifying individuals.

The access period starts from June 2023

It will be available only to researchers working in academic and scientific institutions.

Researchers working in academic and scientific institutions can use only part of the data, such as the information related to the main outcome, in their scientific researches and refer to the results obtained from them, but the right of any new analysis on the delivered data, do not have.

Full name of the researcher: Ghazal Safa/Gmail: ghazal.safa94@gmail.com

Only a part of the data, such as the information related to the main outcome, will be sent to researchers working in academic and scientific institutions after receiving the e-mail from the researcher.